4601 - 4650 of 8616 Results
Title
Year
- Antipsychotic drug efficacy correlates with the modulation of D1 rather than D2 receptor-expressing striatal projection neurons2023OPENTitle: Antipsychotic drug efficacy correlates with the modulation of D1 rather than D2 receptor-expressing striatal projection neuronsJournal Name: Nature NeurosciencePublisher: Springer Science and Business Media LLCVol: 26Issue #: 8Start Page: 1417End Page: 1428Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/s41593-023-01390-9Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/10842629Citation Count: 49
- Validation of Serum Neurofilament Light Chain as a Biomarker of Parkinson's Disease Progression2020OPENTitle: Validation of Serum Neurofilament Light Chain as a Biomarker of Parkinson's Disease ProgressionJournal Name: Movement DisordersPublisher: WileyVol: 35Issue #: 11Start Page: 1999End Page: 2008Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.28206Best OA location URL: https://escholarship.org/content/qt1dx4582d/qt1dx4582d.pdfCitation Count: 148
- Automated, multiparametric monitoring of respiratory biomarkers and vital signs in clinical and home settings for COVID-19 patients2021OPENTitle: Automated, multiparametric monitoring of respiratory biomarkers and vital signs in clinical and home settings for COVID-19 patientsJournal Name: Proceedings of the National Academy of SciencesPublisher: Proceedings of the National Academy of SciencesVol: 118Issue #: 19Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1073/pnas.2026610118Best OA location URL: https://escholarship.org/content/qt1p8123ct/qt1p8123ct.pdfCitation Count: 86
- Novel decision algorithm to discriminate parkinsonism with combined blood and imaging biomarkers2020OPENTitle: Novel decision algorithm to discriminate parkinsonism with combined blood and imaging biomarkersJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 77Issue #:Start Page: 57End Page: 63Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.05.033Best OA location URL: http://www.prd-journal.com/article/S1353802020301504/pdfCitation Count: 23
-
OPENTitle: Decreased vestibular efficacy contributes to abnormal balance in Parkinson's diseaseJournal Name: Journal of the Neurological SciencesPublisher: Elsevier BVVol: 440Issue #:Start Page: 120357End Page: 120357Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.jns.2022.120357Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/9444904Citation Count: 13
-
OPENTitle: α‐Synuclein in blood cells differentiates Parkinson’s disease from healthy controlsJournal Name: Annals of Clinical and Translational NeurologyPublisher: WileyVol: 6Issue #: 12Start Page: 2426End Page: 2436Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/acn3.50944Best OA location URL: https://hdl.handle.net/11384/134333Citation Count: 35
- Evidence for early and progressive ultrasonic vocalization and oromotor deficits in a PINK1 gene knockout rat model of Parkinson's disease2015OPENTitle: Evidence for early and progressive ultrasonic vocalization and oromotor deficits in a PINK1 gene knockout rat model of Parkinson's diseaseJournal Name: Journal of Neuroscience ResearchPublisher: WileyVol: 93Issue #: 11Start Page: 1713End Page: 1727Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/jnr.23625Citation Count: 95
- Time course and magnitude of alpha-synuclein inclusion formation and nigrostriatal degeneration in the rat model of synucleinopathy triggered by intrastriatal α-synuclein preformed fibrils2019OPENTitle: Time course and magnitude of alpha-synuclein inclusion formation and nigrostriatal degeneration in the rat model of synucleinopathy triggered by intrastriatal α-synuclein preformed fibrilsJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 130Issue #:Start Page: 104525End Page: 104525Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nbd.2019.104525Best OA location URL: https://doi.org/10.1016/j.nbd.2019.104525Citation Count: 82
- A potential patient stratification biomarker for Parkinson´s disease based on LRRK2 kinase-mediated centrosomal alterations in peripheral blood-derived cells2024OPENTitle: A potential patient stratification biomarker for Parkinson´s disease based on LRRK2 kinase-mediated centrosomal alterations in peripheral blood-derived cellsJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-023-00624-8Best OA location URL: https://www.nature.com/articles/s41531-023-00624-8.pdfCitation Count: 15
- Assessment of test-retest reproducibility of [18F]SynVesT-1, a novel radiotracer for PET imaging of synaptic vesicle glycoprotein 2A2021RESTRICTEDTitle: Assessment of test-retest reproducibility of [18F]SynVesT-1, a novel radiotracer for PET imaging of synaptic vesicle glycoprotein 2AJournal Name: European Journal of Nuclear Medicine and Molecular ImagingPublisher: Springer Science and Business Media LLCVol: 48Issue #: 5Start Page: 1327End Page: 1338Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s00259-020-05149-3Citation Count: 46
-
OPENTitle: Cryogel microcarriers for sustained local delivery of growth factors to the brainJournal Name: Journal of Controlled ReleasePublisher: Elsevier BVVol: 369Issue #:Start Page: 404End Page: 419Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.jconrel.2024.03.023Best OA location URL: https://ars.els-cdn.com/content/image/1-s2.0-S0168365924001755-ga1_lrg.jpgCitation Count: 6
- Common signatures of differential microRNA expression in Parkinson’s and Alzheimer’s disease brains2022OPENTitle: Common signatures of differential microRNA expression in Parkinson’s and Alzheimer’s disease brainsJournal Name: Brain CommunicationsPublisher: Oxford University Press (OUP)Vol: 4Issue #: 6Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1093/braincomms/fcac274Best OA location URL: https://academic.oup.com/braincomms/article-pdf/4/6/fcac274/46907691/fcac274.pdfCitation Count: 18
-
OPENTitle: Cholinergic system correlates of postural control changes in Parkinson’s disease freezersJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 146Issue #: 8Start Page: 3243End Page: 3257Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/brain/awad134Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/10393403Citation Count: 21
- Characterization of intracellular elevation of glutathione (GSH) with glutathione monoethyl ester and GSH in brain and neuronal cultures: Relevance to Parkinson's disease2006OPENTitle: Characterization of intracellular elevation of glutathione (GSH) with glutathione monoethyl ester and GSH in brain and neuronal cultures: Relevance to Parkinson's diseaseJournal Name: Experimental NeurologyPublisher: Elsevier BVVol: 203Issue #: 2Start Page: 512End Page: 520Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.expneurol.2006.09.004Best OA location URL: http://doi.org/10.1016/j.expneurol.2006.09.004Citation Count: 97
- Bioinspired Theranostic Coordination Polymer Nanoparticles for Intranasal Dopamine Replacement in Parkinson’s Disease2021OPENTitle: Bioinspired Theranostic Coordination Polymer Nanoparticles for Intranasal Dopamine Replacement in Parkinson’s DiseaseJournal Name: ACS NanoPublisher: American Chemical Society (ACS)Vol: 15Issue #: 5Start Page: 8592End Page: 8609Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1021/acsnano.1c00453Best OA location URL: https://pubs.acs.org/doi/pdf/10.1021/acsnano.1c00453Citation Count: 79
- Sphingolipid changes in Parkinson L444P GBA mutation fibroblasts promote α-synuclein aggregation2021OPENTitle: Sphingolipid changes in Parkinson L444P GBA mutation fibroblasts promote α-synuclein aggregationJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 145Issue #: 3Start Page: 1038End Page: 1051Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc, cc-by-ncDOI - Digital Object Identifier: 10.1093/brain/awab371Best OA location URL: https://academic.oup.com/brain/article-pdf/145/3/1038/43499976/awab371.pdfCitation Count: 61
- Cerebrospinal fluid, plasma, and saliva in the BioFIND study: Relationships among biomarkers and Parkinson's disease Features2017OPENTitle: Cerebrospinal fluid, plasma, and saliva in the BioFIND study: Relationships among biomarkers and Parkinson's disease FeaturesJournal Name: Movement DisordersPublisher: WileyVol: 33Issue #: 2Start Page: 282End Page: 288Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.27232Best OA location URL: https://escholarship.org/content/qt7gp9f6h5/qt7gp9f6h5.pdfCitation Count: 138
- Progression of tremor in early stages of Parkinson’s disease: a clinical and neuroimaging study2017OPENTitle: Progression of tremor in early stages of Parkinson’s disease: a clinical and neuroimaging studyJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 141Issue #: 3Start Page: 811End Page: 821Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/brain/awx376Best OA location URL: https://academic.oup.com/brain/article-pdf/141/3/811/25046389/awx376.pdfCitation Count: 135
- Predicting PY motif-mediated protein-protein interactions in the Nedd4 family of ubiquitin ligases2021OPENTitle: Predicting PY motif-mediated protein-protein interactions in the Nedd4 family of ubiquitin ligasesJournal Name: PLOS ONEPublisher: Public Library of Science (PLoS)Vol: 16Issue #: 10Start Page: e0258315End Page: e0258315Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0258315Best OA location URL: https://doi.org/10.1371/journal.pone.0258315Citation Count: 16
- Physiotherapy improves motor function in patients with the Parkinson variant of multiple system atrophy: A prospective trial2019RESTRICTEDTitle: Physiotherapy improves motor function in patients with the Parkinson variant of multiple system atrophy: A prospective trialJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 67Issue #:Start Page: 60End Page: 65Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.09.026Citation Count: 32
-
RESTRICTEDTitle: Structural basis for the pathogenicity of parkin catalytic domain mutantsJournal Name: Journal of Biological ChemistryPublisher: Elsevier BVVol: 301Issue #: 1Start Page: 108051End Page: 108051Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.jbc.2024.108051Best OA location URL: https://doi.org/10.1016/j.jbc.2024.108051Citation Count: 1
-
RESTRICTEDTitle: Dopamine-mediated improvements in dynamic balance control in Parkinson’s diseaseJournal Name: Gait & PosturePublisher: Elsevier BVVol: 82Issue #:Start Page: 68End Page: 74Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.gaitpost.2020.08.132Citation Count: 9
- Large-scale deep multi-layer analysis of Alzheimer’s disease brain reveals strong proteomic disease-related changes not observed at the RNA level2022OPENTitle: Large-scale deep multi-layer analysis of Alzheimer’s disease brain reveals strong proteomic disease-related changes not observed at the RNA levelJournal Name: Nature NeurosciencePublisher: Springer Science and Business Media LLCVol: 25Issue #: 2Start Page: 213End Page: 225Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41593-021-00999-yBest OA location URL: https://escholarship.org/content/qt9gr017hq/qt9gr017hq.pdfCitation Count: 412
- Preclinical modeling of chronic inhibition of the Parkinson’s disease associated kinase LRRK2 reveals altered function of the endolysosomal system in vivo2021OPENTitle: Preclinical modeling of chronic inhibition of the Parkinson’s disease associated kinase LRRK2 reveals altered function of the endolysosomal system in vivoJournal Name: Molecular NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 16Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13024-021-00441-8Best OA location URL: https://molecularneurodegeneration.biomedcentral.com/counter/pdf/10.1186/s13024-021-00441-8Citation Count: 46
- Benchmarking of a multi‐biomarker low‐volume panel for Alzheimer's disease and related dementia research2024OPENTitle: Benchmarking of a multi‐biomarker low‐volume panel for Alzheimer's disease and related dementia researchJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 21Issue #: 2Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/alz.14413Best OA location URL: https://doi.org/10.1002/alz.14413Citation Count: 13
-
RESTRICTEDTitle: Can We Treat Neurodegenerative Proteinopathies by Enhancing Protein Degradation?Journal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 7Start Page: 1346End Page: 1359Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.29058Citation Count: 17
- LRRK2 levels and phosphorylation in Parkinson's disease brain and cases with restricted Lewy bodies2016RESTRICTEDTitle: LRRK2 levels and phosphorylation in Parkinson's disease brain and cases with restricted Lewy bodiesJournal Name: Movement DisordersPublisher: WileyVol: 32Issue #: 3Start Page: 423End Page: 432Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.26892Citation Count: 44
-
OPENTitle: Tau immunoreactivity in peripheral tissues of human aging and select tauopathiesJournal Name: Neuroscience LettersPublisher: Elsevier BVVol: 696Issue #:Start Page: 132End Page: 139Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neulet.2018.12.031Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7357994Citation Count: 49
- Enhanced CNS transduction from AAV.PHP.eB infusion into the cisterna magna of older adult rats compared to AAV92021OPENTitle: Enhanced CNS transduction from AAV.PHP.eB infusion into the cisterna magna of older adult rats compared to AAV9Journal Name: Gene TherapyPublisher: Springer Science and Business Media LLCVol: 29Issue #: 6Start Page: 390End Page: 397Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41434-021-00244-yBest OA location URL: https://www.nature.com/articles/s41434-021-00244-y.pdfCitation Count: 31
- Mitochondrial DNA deletions in the cerebrospinal fluid of patients with idiopathic REM sleep behaviour disorder2024OPENTitle: Mitochondrial DNA deletions in the cerebrospinal fluid of patients with idiopathic REM sleep behaviour disorderJournal Name: eBioMedicinePublisher: Elsevier BVVol: 102Issue #:Start Page: 105065End Page: 105065Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1016/j.ebiom.2024.105065Best OA location URL: http://www.thelancet.com/article/S2352396424001002/pdfCitation Count: 6
- MTOR Pathway-Based Discovery of Genetic Susceptibility to L-DOPA-Induced Dyskinesia in Parkinson’s Disease Patients2018RESTRICTEDTitle: MTOR Pathway-Based Discovery of Genetic Susceptibility to L-DOPA-Induced Dyskinesia in Parkinson’s Disease PatientsJournal Name: Molecular NeurobiologyPublisher: Springer Science and Business Media LLCVol: 56Issue #: 3Start Page: 2092End Page: 2100Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s12035-018-1219-1Citation Count: 21
-
OPENTitle: Predicting alpha-synuclein pathology by REM sleep behavior disorder diagnosisJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 55Issue #:Start Page: 92End Page: 96Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2018.05.020Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7850633Citation Count: 25
-
RESTRICTEDTitle: Colonic inflammation in Parkinson's diseaseJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 50Issue #:Start Page: 42End Page: 48Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2012.09.007Citation Count: 539
-
OPENTitle: Neurofilament Light Chain as a Biomarker for Cognitive Decline in Parkinson DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 12Start Page: 2945End Page: 2950Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.28779Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8688198Citation Count: 135
- Preclinical and clinical assessment of inhaled levodopa for OFF episodes in Parkinson’s disease2016RESTRICTEDTitle: Preclinical and clinical assessment of inhaled levodopa for OFF episodes in Parkinson’s diseaseJournal Name: Science Translational MedicinePublisher: American Association for the Advancement of Science (AAAS)Vol: 8Issue #: 360Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1126/scitranslmed.aad8858Citation Count: 68
- Fecal markers of intestinal inflammation and intestinal permeability are elevated in Parkinson's disease2018RESTRICTEDTitle: Fecal markers of intestinal inflammation and intestinal permeability are elevated in Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 50Issue #:Start Page: 104End Page: 107Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2018.02.022Citation Count: 263
- LUBAC assembles a ubiquitin signaling platform at mitochondria for signal amplification and transport of NF‐κB to the nucleus2022OPENTitle: LUBAC assembles a ubiquitin signaling platform at mitochondria for signal amplification and transport of NF‐κB to the nucleusJournal Name: The EMBO JournalPublisher: Springer Science and Business Media LLCVol: 41Issue #: 24Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.15252/embj.2022112006Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.15252/embj.2022112006Citation Count: 26
-
OPENTitle: Bach1 derepression is neuroprotective in a mouse model of Parkinson’s diseaseJournal Name: Proceedings of the National Academy of SciencesPublisher: Proceedings of the National Academy of SciencesVol: 118Issue #: 45Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1073/pnas.2111643118Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8694049Citation Count: 63
-
OPENTitle: A comprehensive head-to-head comparison of key plasma phosphorylated tau 217 biomarker testsJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 148Issue #: 2Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1093/brain/awae346Best OA location URL: https://doi.org/10.1093/brain/awae346Citation Count: 14
- DPP-4 inhibitors sitagliptin and PF-00734,200 mitigate dopaminergic neurodegeneration, neuroinflammation and behavioral impairment in the rat 6-OHDA model of Parkinson’s disease2024OPENTitle: DPP-4 inhibitors sitagliptin and PF-00734,200 mitigate dopaminergic neurodegeneration, neuroinflammation and behavioral impairment in the rat 6-OHDA model of Parkinson’s diseaseJournal Name: GeroSciencePublisher: Springer Science and Business Media LLCVol: 46Issue #: 5Start Page: 4349End Page: 4371Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s11357-024-01116-0Best OA location URL: https://link.springer.com/content/pdf/10.1007/s11357-024-01116-0.pdfCitation Count: 11
- Striatal shape abnormalities as novel neurodevelopmental endophenotypes in schizophrenia: A longitudinal study2014OPENTitle: Striatal shape abnormalities as novel neurodevelopmental endophenotypes in schizophrenia: A longitudinal studyJournal Name: Human Brain MappingPublisher: WileyVol: 36Issue #: 4Start Page: 1458End Page: 1469Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/hbm.22715Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/hbm.22715?download=trueCitation Count: 65
- PathoFact: a pipeline for the prediction of virulence factors and antimicrobial resistance genes in metagenomic data2021OPENTitle: PathoFact: a pipeline for the prediction of virulence factors and antimicrobial resistance genes in metagenomic dataJournal Name: MicrobiomePublisher: Springer Science and Business Media LLCVol: 9Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s40168-020-00993-9Best OA location URL: https://microbiomejournal.biomedcentral.com/track/pdf/10.1186/s40168-020-00993-9Citation Count: 145
-
OPENTitle: Parkinson’s disease neurons exhibit alterations in mitochondrial quality control proteinsJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 9Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1038/s41531-023-00564-3Best OA location URL: https://www.nature.com/articles/s41531-023-00564-3.pdfCitation Count: 19
- Vestibular Sensory Conflict During Postural Control, Freezing of Gait, and Falls in Parkinson's Disease2022OPENTitle: Vestibular Sensory Conflict During Postural Control, Freezing of Gait, and Falls in Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 11Start Page: 2257End Page: 2262Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.29189Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.29189Citation Count: 21
- Antibody‐based methods for the measurement of α‐synuclein concentration in human cerebrospinal fluid – method comparison and round robin study2018OPENTitle: Antibody‐based methods for the measurement of α‐synuclein concentration in human cerebrospinal fluid – method comparison and round robin studyJournal Name: Journal of NeurochemistryPublisher: WileyVol: 149Issue #: 1Start Page: 126End Page: 138Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1111/jnc.14569Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/jnc.14569Citation Count: 50
- Active site alanine mutations convert deubiquitinases into high‐affinity ubiquitin‐binding proteins2018OPENTitle: Active site alanine mutations convert deubiquitinases into high‐affinity ubiquitin‐binding proteinsJournal Name: EMBO reportsPublisher: Springer Science and Business Media LLCVol: 19Issue #: 10Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.15252/embr.201745680Best OA location URL: https://doi.org/10.15252/embr.201745680Citation Count: 51
- ZEBRA: a hierarchically integrated gene expression atlas of the murine and human brain at single-cell resolution2023OPENTitle: ZEBRA: a hierarchically integrated gene expression atlas of the murine and human brain at single-cell resolutionJournal Name: Nucleic Acids ResearchPublisher: Oxford University Press (OUP)Vol: 52Issue #: D1Start Page: D1089End Page: D1096Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1093/nar/gkad990Best OA location URL: https://academic.oup.com/nar/advance-article-pdf/doi/10.1093/nar/gkad990/52947155/gkad990.pdfCitation Count: 4
-
OPENTitle: Regulation of Memory Formation by the Transcription Factor XBP1Journal Name: Cell ReportsPublisher: Elsevier BVVol: 14Issue #: 6Start Page: 1382End Page: 1394Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.celrep.2016.01.028Best OA location URL: http://www.cell.com/article/S2211124716000498/pdfCitation Count: 154
-
OPENTitle: A blood-based marker of mitochondrial DNA damage in Parkinson’s diseaseJournal Name: Science Translational MedicinePublisher: American Association for the Advancement of Science (AAAS)Vol: 15Issue #: 711Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1126/scitranslmed.abo1557Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/11135133Citation Count: 53
- The highly selective mGlu2 receptor positive allosteric modulator LY‐487,379 alleviates l‐DOPA‐induced dyskinesia in the 6‐OHDA‐lesioned rat model of Parkinson's disease2020RESTRICTEDTitle: The highly selective mGlu2 receptor positive allosteric modulator LY‐487,379 alleviates l‐DOPA‐induced dyskinesia in the 6‐OHDA‐lesioned rat model of Parkinson's diseaseJournal Name: European Journal of NeurosciencePublisher: WileyVol: 51Issue #: 12Start Page: 2412End Page: 2422Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1111/ejn.14679Citation Count: 16